Literature DB >> 17405780

Evaluation of the in vivo efficacy of topical tobramycin against Pseudomonas sinonasal biofilms.

Alexander G Chiu1, Marcelo B Antunes, James N Palmer, Noam A Cohen.   

Abstract

BACKGROUND: There is increasing evidence that bacterial biofilms are present within the sinonasal mucosa of patients with medically recalcitrant chronic rhinosinusitis. The antibiotic concentrations needed to eradicate biofilms are much higher than those commonly used and pose an increased risk for systemic side effects. Topical medications are an alternative approach to deliver high concentrations to the mucosa while limiting systemic side effects. This is the first study to evaluate the effects of a topical antibiotic on Pseudomonas biofilms in an animal model of sinusitis.
METHODS: Pseudomonas sinusitis was established in nine rabbits. An irrigation catheter was placed within the lumen of the maxillary sinus, and the rabbits were irrigated with 7 days of normal saline or varying concentrations of tobramycin diluted in normal saline. Bacterial cfu were determined for nasal lavage fluid as well as physically disrupted mucosa, and scanning electron microscopy (SEM) of the mucosal surface was performed at the end of the study.
RESULTS: Increasing concentrations of topical tobramycin resulted in the eradication of viable bacteria within the lumen of the sinus but did not eradicate Pseudomonas attached to the mucosa. SEM detected biofilms within the mucosa even in those rabbits treated with high concentrations of topical tobramycin.
CONCLUSIONS: Bacterial biofilms attached to the sinonasal mucosa are resistant to topical saline and tobramycin irrigation. SEM was useful in the identification of biofilms, but did not provide a quantitative evaluation for efficacy of treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17405780     DOI: 10.1093/jac/dkm087

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  14 in total

1.  Comment on: Effect of topical ofloxacin on bacterial biofilms in refractory post-sinus surgery rhino-sinusitis.

Authors:  Satvinder Singh Bakshi
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-01-04       Impact factor: 2.503

2.  Topical antibiotic therapy of chronic rhinosinusitis.

Authors:  Richard H Comstock; Kent Lam; Suzette Mikula
Journal:  Curr Infect Dis Rep       Date:  2010-03       Impact factor: 3.725

3.  Resveratrol and ivacaftor are additive G551D CFTR-channel potentiators: therapeutic implications for cystic fibrosis sinus disease.

Authors:  Do-Yeon Cho; Shaoyan Zhang; Ahmed Lazrak; Jessica W Grayson; Jaime A Peña Garcia; Daniel F Skinner; Dong Jin Lim; Calvin Mackey; Catherine Banks; Sadis Matalon; Bradford A Woodworth
Journal:  Int Forum Allergy Rhinol       Date:  2018-08-27       Impact factor: 3.858

4.  Herbal dry extract BNO 1011 improves clinical and mucociliary parameters in a rabbit model of chronic rhinosinusitis.

Authors:  Do-Yeon Cho; Daniel Skinner; Calvin Mackey; Harold B Lampkin; Jeffrey Brent Elder; Dong Jin Lim; Shaoyan Zhang; Justin McCormick; Guillermo J Tearney; Steven M Rowe; Bradford A Woodworth
Journal:  Int Forum Allergy Rhinol       Date:  2019-01-18       Impact factor: 3.858

5.  Treatment with the Pseudomonas aeruginosa Glycoside Hydrolase PslG Combats Wound Infection by Improving Antibiotic Efficacy and Host Innate Immune Activity.

Authors:  Matthew J Pestrak; Perrin Baker; Sheri Dellos-Nolan; Preston J Hill; Daniel Passos da Silva; Holly Silver; Ira Lacdao; Deepa Raju; Matthew R Parsek; Daniel J Wozniak; P Lynne Howell
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

6.  Tolerance and pharmacokinetics of a ciprofloxacin-coated sinus stent in a preclinical model.

Authors:  Do-Yeon Cho; Kyle Hoffman; Daniel Skinner; Calvin Mackey; Dong Jin Lim; Grant C Alexander; Chae Yun Bae; Dong Keun Han; Ho-Wook Jun; Bradford A Woodworth
Journal:  Int Forum Allergy Rhinol       Date:  2016-12-19       Impact factor: 3.858

Review 7.  Surfactants in the management of rhinopathologies.

Authors:  Philip L Rosen; James N Palmer; Bert W O'Malley; Noam A Cohen
Journal:  Am J Rhinol Allergy       Date:  2013 May-Jun       Impact factor: 2.467

8.  Preclinical therapeutic efficacy of the ciprofloxacin-eluting sinus stent for Pseudomonas aeruginosa sinusitis.

Authors:  Do-Yeon Cho; Dong-Jin Lim; Calvin Mackey; Daniel Skinner; Christopher Weeks; Gobind S Gill; Robert W Hergenrother; William E Swords; Bradford A Woodworth
Journal:  Int Forum Allergy Rhinol       Date:  2018-01-15       Impact factor: 3.858

9.  l-Methionine anti-biofilm activity against Pseudomonas aeruginosa is enhanced by the cystic fibrosis transmembrane conductance regulator potentiator, ivacaftor.

Authors:  Do-Yeon Cho; Dong-Jin Lim; Calvin Mackey; Christopher G Weeks; Jaime A Peña Garcia; Daniel Skinner; Jessica W Grayson; Harrison S Hill; David K Alexander; Shaoyan Zhang; Bradford A Woodworth
Journal:  Int Forum Allergy Rhinol       Date:  2018-02-07       Impact factor: 3.858

10.  Understanding the Role of Biofilms and Superantigens in Chronic Rhinosinusitis.

Authors:  Ivy W Maina; Neil N Patel; Noam A Cohen
Journal:  Curr Otorhinolaryngol Rep       Date:  2018-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.